Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia

Sonia Cerquozzi,1 Carolyn Owen2 1Department of Hematology, University of Calgary, 2Department of Hematology, Tom Baker Cancer Centre, Calgary, AB, Canada Abstract: The introduction of targeted therapy against CD20+ with the monoclonal antibody rituximab has dramatically improved the survival of B-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cerquozzi S, Owen C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/ad072ec049fe487aa308dde7eac61360
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares